Navigation Links
Warner Chilcott to Hold 2009 Annual General Meeting of Shareholders and Special Court-Ordered Meeting of Shareholders
Date:6/26/2009

ARDEE, Ireland, June 26 /PRNewswire-FirstCall/ -- Warner Chilcott Limited announced today that it will hold its 2009 Annual General Meeting of Shareholders (the "Annual Meeting") and a Special Court-Ordered Meeting of Shareholders (the "Special Meeting") on August 5, 2009. At the Special Meeting, the Company's shareholders will be asked to vote in favor of certain matters related to the proposed redomestication of the Company from Bermuda to Ireland. Subject to shareholder approval and the approval of the Supreme Court of Bermuda, the redomestication will result in the creation of a newly formed public holding company organized in, and a tax resident of, Ireland. The new company, Warner Chilcott plc, will replace Warner Chilcott Limited as the ultimate public holding company. The Annual Meeting will be held at 2:00 p.m. (local time). The Special Meeting will be held immediately following the conclusion of the Annual Meeting. Both meetings will take place at The K Club, Straffan, Co Kildare, Ireland.

A definitive proxy statement for the Annual Meeting and the Special Meeting has been filed with the Securities and Exchange Commission (the "SEC") and is expected to be mailed on or about June 29, 2009 to all shareholders of the Company as of June 19, 2009, the record date for both the Annual Meeting and the Special Meeting. During the meetings, shareholders will vote on the proposals listed in the definitive proxy statement.

The Company does not expect the proposed redomestication will have any material impact on its financial results. The Company will, upon completion of the proposed redomestication, continue to be subject to SEC reporting requirements, and the Company's shares will continue to be listed on the Nasdaq under the symbol "WCRX". Additional information on the proposed redomestication, including associated benefits and risks, is contained in the definitive proxy statement.

Important Information for Shareholders

This communication is for informational purposes only and is not a substitute for any proxy statement and related documents that the Company has filed and may file with the SEC. The Company has filed with the SEC a definitive proxy statement and intends to mail the definitive proxy statement on or about June 29, 2009 to all shareholders of Warner Chilcott as of June 19, 2009. Shareholders are urged to read the definitive proxy statement in its entirety because it contains important information about the proposed redomestication. The definitive proxy statement is, and other documents filed or to be filed by the Company with the SEC are, or will be, available free of charge at the SEC's web site (www.sec.gov) and at the Company's web site (www.wcrx.com).

The Company and its directors and executive officers and other persons may be deemed participants in the solicitation of proxies from the Company's stockholders in connection with the proposed redomestication. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the Company's shareholders in connection with the proposed redomestication is set forth in the definitive proxy statement.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G


'/>"/>
SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
2. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
3. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
4. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
5. Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
6. Warner Chilcott Announces 2008 Financial Guidance
7. Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecoms IP VPN
10. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
11. Warner Chilcott Announces Settlement of Securities Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Joshua Rosenthal, PhD, Chief Scientific Officer ... use newly released government data on populations and physicians to better calculate risk ... the value they create to succeed in new economic models for value based ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now online for ... 2016 Conference, which is being held May 25-29 at the Loews Chicago O’Hare Hotel, ... interventions and causes of chronic illness in children. , Very recent articles have cited ...
(Date:2/7/2016)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... ability to correct pelvic organ prolapse with the latest techniques and the most ... greatest risk for pelvic organ prolapse, particularly after menopause. Other risk factors include ...
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, Inc. ... organizations with the tools and information to lower the costs, and increase the ... cost of providing employee healthcare benefits by as much as 22%:, + ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This ... an estimated 5000 perioperative nurses in attendance to study the latest evidence-based ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide Radiology ... significant growth as next generation systems provide a ... radiology for cancer surgery. New systems pinpoint the ... that has been such a problem previously, limiting ... Radiosurgery robots take cancer surgery far beyond what ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... , Feb. 4, 2016 Global ... competitive market to drive long-term market growth ... common set of chronic disorders that affect 5–7% ... in terms of their symptoms and key patient ... dysregulation of immune pathways and an inappropriate immune ...
Breaking Medicine Technology: